Pravastatin Reduces Acute Phase Response of Zoledronic Acid

Clinical trial NCT04719481 · UNKNOWN

Trial details

NCT number: NCT04719481
Sponsor: Peking University Third Hospital
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Postmenopausal Osteoporosis

Start date: 2021-11-01
Primary completion: 2021-11-01
Enrollment: 110

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.